Children’s National welcomes hematology and sickle cell experts, expands team
June 07, 2017
As Children’s National Health System emerges as a leader in Pediatric Hematology, the Center for Cancer and Blood Disorders
proudly announces two new physician leaders in the Division of Hematology
and the Comprehensive Sickle Cell Disease Program
. Joining Children’s National this summer, Suvankar Majumdar, M.D., will lead our blood disorders team as the Division Chief of Hematology. Andrew Campbell, M.D., will join the team as the Director of the Comprehensive Sickle Cell Disease Program, the largest such program in the Washington, D.C., area. Both prominent physician-scientists
, Drs. Majumdar and Campbell will help us to advance the science behind our medicine and provide the best possible care to patients with blood disorders in our region.
Suvankar (Seve) Majumdar, M.D.
Chief, Division of Hematology
Dr. Majumdar was born in Zambia, attended the University of Zimbabwe College of Health Sciences and conducted his postdoctoral medical education at the University of Mississippi. Dr. Majumdar served as the Director of the Comprehensive Pediatric Sickle Cell Program at the University of Mississippi Medical Center. He previously directed the Mississippi Hemophilia Treatment Center and is a recognized leader in hematology and sickle cell disease. In addition to his broad clinical expertise, Dr. Majumdar is an accomplished researcher, and a Principal Investigator of NIH-funded studies.
Andrew (Drew) Campbell, M.D.
Director, Comprehensive Sickle Cell Disease Program
Dr. Campbell's distinguished training and career path began at Morehouse College. He continued medical school at Case Western Reserve University and completed post graduate training at Massachusetts General Hospital (Harvard) and Lurie Children's Hospital (Northwestern University). Prior to joining Children’s National, he was Director of the Comprehensive Sickle Cell Center at the University of Michigan, a position he held since 2005. His research interests span several topics in sickle cell disease including pulmonary complications, fetal hemoglobin switching in transgenic sickle cell mice, phenotype/genotype relationships, and renal complications.To learn more about Cardiac Surgery at Children’s National, visit our website or call 202-476-2811.
The Children’s National Division of Hematology includes the most comprehensive pediatric blood disorders team in the Washington, D.C., area. The Comprehensive Sickle Cell Disease Program is among the largest in the country, treating more than 1,400 children and young adults with all types of sickle cell disease.
Learn more about Hematology and the Sickle Cell Disease Program. To schedule an appointment, call 1-888-884-BEAR (2327).